2-piperidone has been researched along with Disease Exacerbation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SE; Han, SJ; Heo, YJ; Jeon, JY; Kang, Y; Kim, DJ; Kim, HJ; Lee, KW; Lee, N | 1 |
| Burzynski, GS; Burzynski, SR; Janicki, TJ; Marszalek, A | 1 |
| Clerici, CA; Massimino, M | 1 |
| Di Rocco, C | 1 |
| Bendas, G; Bisht, S; Brossart, P; Feldmann, G; Holdenrieder, S; Nolting, J; Rupp, A; Schlesinger, M; Schubert, R; Wenzel, J | 1 |
| Bestak, M; Burzynski, SR; Janicki, TJ; Jurida, GF; Khan, MI; Lewy, RI; Szymkowski, BG; Weaver, RA | 1 |
| Burzynski, SR; Dolgopolov, V; Janicki, T; Jurida, G; Khan, M; Szymkowski, B; Weaver, RA | 1 |
5 trial(s) available for 2-piperidone and Disease Exacerbation
| Article | Year |
|---|---|
The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Brain Stem Neoplasms; Child; Child, Preschool; Disease Progression; Drug Combinations; Female; Glioma; Glutamine; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Pons; Survival Rate | 2014 |
Commentary: The response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Biomedical Research; Brain Stem Neoplasms; Child; Child, Preschool; Disease Progression; Drug Combinations; Female; Glioma; Glutamine; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Pons; Prognosis; Survival Rate; Treatment Outcome | 2014 |
Main editor's comment to the paper: the response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma. Stanislaw R. Burzynski, Tomasz J. Janicki
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Brain Stem Neoplasms; Child; Child, Preschool; Disease Progression; Drug Combinations; Female; Glioma; Glutamine; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Pons; Survival Rate; Treatment Outcome | 2014 |
Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report.
Topics: Adolescent; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Glioma; Glutamine; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome | 2004 |
Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1.
Topics: Antineoplastic Agents; Benzeneacetamides; Brain Neoplasms; Child, Preschool; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Glutamine; Humans; Infant; Male; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome | 2005 |
2 other study(ies) available for 2-piperidone and Disease Exacerbation
| Article | Year |
|---|---|
Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease.
Topics: Amino Acids; Animals; Benzhydryl Compounds; Choline; Cytokines; Diet, High-Fat; Disease Models, Animal; Disease Progression; Glucosides; Inflammation; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Liver; Macrophage Activation; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phosphorylation; Piperidones; Protective Agents; Pyrimidines | 2022 |
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
Topics: Animals; Antineoplastic Agents; Benzylidene Compounds; Cell Line, Tumor; Cell Survival; Deoxycytidine; Disease Progression; Drug Compounding; Drug Therapy, Combination; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Injections, Subcutaneous; Liposomes; Mice; NF-kappa B; Pancreatic Neoplasms; Phosphorylation; Piperidones; Signal Transduction; Xenograft Model Antitumor Assays | 2016 |